Efficacy of fasudil in COPD-associated pulmonary arterial hypertension: meta-analysis of randomized controlled trials
Abstract
Background: Pulmonary arterial hypertension (PAH) is a serious complication of chronic obstructive pulmonary disease (COPD) that markedly worsens functional capacity and prognosis. Fasudil, a selective Rho-kinase inhibitor, has shown vasodilatory and vascular-protective effects; however, its therapeutic value in COPD-associated PAH has not been systematically quantified.
Objective: The objective of the study was to evaluate the efficacy of fasudil as an adjunctive therapy for COPD patients with PAH through a systematic review and meta-analysis of randomized controlled trials (RCTs).
Methods: Eight electronic databases were searched from inception to April 2024 for RCTs comparing fasudil plus conventional therapy with conventional therapy alone. Primary outcomes included overall treatment effectiveness and pulmonary artery systolic pressure (PASP). Secondary outcomes were blood oxygen saturation (SaO₂), arterial oxygen tension (PaO₂), and 6-min walk distance (6MWT). Data were pooled using fixed- or random-effects models according to heterogeneity.
Results: A total of 11 RCTs involving 865 participants met the inclusion criteria. Fasudil significantly increased the overall effective rate (risk ratio = 1.18, 95% CI = 1.05-1.31, p = 0.004) and reduced PASP (mean difference = -9.42 mmHg, 95% CI = -10.73 to -8.12, p p = 0.002). Functional capacity improved substantially, with a 51.96-m gain in 6MWT distance (95% CI = 36.84-67.08, p < 0.001), exceeding the minimal clinically…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 865 participants or records.
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.